Given that our published in silico analysis suggested that CDX2 is a predicted mRNA target of LIN28B (8, 11), we hypothesized that posttranscriptional regulation of CDX2 by LIN28B may promote differentiation in LIN28B-overexpressing CRC tumors. The gene discussed is CDX2; the disease is colorectal carcinoma.